233 related articles for article (PubMed ID: 21491142)
21. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence.
Han DH; Yoon SJ; Sung YH; Lee YS; Kee BS; Lyoo IK; Renshaw PF; Cho SC
Compr Psychiatry; 2008; 49(4):387-92. PubMed ID: 18555060
[TBL] [Abstract][Full Text] [Related]
22. BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence.
Iamjan SA; Thanoi S; Watiktinkorn P; Nudmamud-Thanoi S; Reynolds GP
Pharmacogenomics; 2015; 16(14):1541-5. PubMed ID: 26401760
[TBL] [Abstract][Full Text] [Related]
23. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
24. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis.
Ujike H; Sakai A; Nakata K; Tanaka Y; Kodaka T; Okahisa Y; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
Ann N Y Acad Sci; 2006 Aug; 1074():90-6. PubMed ID: 17105906
[TBL] [Abstract][Full Text] [Related]
25. A Pilot Assessment of the Effects of HIV and Methamphetamine Dependence on Socially Dysregulated Behavior in the Human Behavioral Pattern Monitor.
Miranda A; Perry W; Umlauf A; Young JW; Morgan EE; Minassian A;
AIDS Behav; 2023 Aug; 27(8):2617-2628. PubMed ID: 36738342
[TBL] [Abstract][Full Text] [Related]
26. Decreased dopamine activity predicts relapse in methamphetamine abusers.
Wang GJ; Smith L; Volkow ND; Telang F; Logan J; Tomasi D; Wong CT; Hoffman W; Jayne M; Alia-Klein N; Thanos P; Fowler JS
Mol Psychiatry; 2012 Sep; 17(9):918-25. PubMed ID: 21747399
[TBL] [Abstract][Full Text] [Related]
27. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
Ikeda M; Okahisa Y; Aleksic B; Won M; Kondo N; Naruse N; Aoyama-Uehara K; Sora I; Iyo M; Hashimoto R; Kawamura Y; Nishida N; Miyagawa T; Takeda M; Sasaki T; Tokunaga K; Ozaki N; Ujike H; Iwata N
Neuropsychopharmacology; 2013 Sep; 38(10):1864-70. PubMed ID: 23594818
[TBL] [Abstract][Full Text] [Related]
28. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
Ujike H; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Sora I; Iyo M; Katsu T; Nomura A; Nakata K; Ozaki N
Pharmacogenomics J; 2003; 3(4):242-7. PubMed ID: 12931138
[TBL] [Abstract][Full Text] [Related]
29. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
Ballard ME; Dean AC; Mandelkern MA; London ED
PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
[TBL] [Abstract][Full Text] [Related]
30. Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk.
Mehta SR; Iudicello JE; Lin J; Ellis RJ; Morgan E; Okwuegbuna O; Cookson D; Karris M; Saloner R; Heaton R; Grant I; Letendre S;
Drug Alcohol Depend; 2021 Apr; 221():108639. PubMed ID: 33621803
[TBL] [Abstract][Full Text] [Related]
31. Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis.
Montoya JL; Umlauf A; Abramson I; Badiee J; Woods SP; Atkinson JH; Grant I; Moore DJ;
J Affect Disord; 2013 Nov; 151(2):728-737. PubMed ID: 24012068
[TBL] [Abstract][Full Text] [Related]
32. Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence.
Veerasakul S; Watiktinkorn P; Thanoi S; Reynolds GP; Nudmamud-Thanoi S
Pharmacogenomics; 2017 Jan; 18(1):17-22. PubMed ID: 27967329
[TBL] [Abstract][Full Text] [Related]
33. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
[TBL] [Abstract][Full Text] [Related]
34. Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy.
Zhang R; Li J; Wu Y; Liang S; Xu L
Genet Test Mol Biomarkers; 2021 Jan; 25(1):20-30. PubMed ID: 33372861
[No Abstract] [Full Text] [Related]
35. HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.
Jacobs MM; Murray J; Byrd DA; Hurd YL; Morgello S
J Neurovirol; 2013 Oct; 19(5):495-504. PubMed ID: 24078558
[TBL] [Abstract][Full Text] [Related]
36. Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients.
Zhao L; Lin Y; Lao G; Wang Y; Guan L; Wei J; Yang Z; Ni P; Li X; Jiang Z; Li T; Hao X; Lin D; Cao L; Ma X
J Affect Disord; 2015 Jan; 170():85-90. PubMed ID: 25233244
[TBL] [Abstract][Full Text] [Related]
37. Association study of the tumor necrosis factor-alpha gene and its 1A receptor gene with methamphetamine dependence.
Nomura A; Ujike H; Tanaka Y; Kishimoto M; Otani K; Morita Y; Morio A; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
Ann N Y Acad Sci; 2006 Aug; 1074():116-24. PubMed ID: 17105909
[TBL] [Abstract][Full Text] [Related]
38. Methamphetamine-associated dysregulation of the hypothalamic-pituitary-thyroid axis.
Jones DL; Carrico AW; Babayigit S; Rodriguez VJ; Aguila C; Kumar M
J Behav Med; 2018 Dec; 41(6):792-797. PubMed ID: 29777500
[TBL] [Abstract][Full Text] [Related]
39. Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population.
Kishi T; Fukuo Y; Okochi T; Kitajima T; Kawashima K; Naitoh H; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
Drug Alcohol Depend; 2011 Jan; 113(1):1-7. PubMed ID: 20705401
[TBL] [Abstract][Full Text] [Related]
40. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.
Kishi T; Tsunoka T; Ikeda M; Kitajima T; Kawashima K; Okochi T; Okumura T; Yamanouchi Y; Kinoshita Y; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
Neuropharmacology; 2010 Feb; 58(2):452-6. PubMed ID: 19747927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
